On February 2, 2026, UBS raised its price target for Intel Corporation to $51, suggesting roughly a 7% upside from recent levels. The upgrade reflects confidence in Intel’s ability to capture renewed market share in both PC and data-center segments. Today’s session saw Intel shares climb over 3%, underpinned by unusually high trading volume of 22.1 million shares and a market capitalization of approximately $239.4 billion. Over the past 12 months, the stock has rallied more than 170% from its annual trough, illustrating investors’ growing conviction in management’s turnaround strategy despite broader tech sector volatility.

Intel continues to benefit from a $9 billion U.S. government grant aimed at bolstering domestic semiconductor manufacturing, but the company has reported year-over-year revenue declines in its most recent quarter and has postponed the opening of key fabrication facilities. These delays have pushed back projected capacity growth timelines and prompted analysts to revise near-term earnings forecasts downward. Management has attributed the slippage to supply-chain disruptions and stringent process yields, emphasizing that full production targets at the new 18A-node plants will now be realized later in 2026.

Intel’s bullish long-term outlook hinges on synchronizing volume production of its 18A process node with robust client commitments under the 14A roadmap through 2027. The 18A inflection represents a fundamental shift in Intel’s foundry competitiveness, narrowing the performance and density gap with industry leaders. Early engagements with major cloud and AI customers signal potential multi-year agreements, and management forecasts that foundry revenue could contribute more than 20% of total company sales by 2027, up from single digits today. Investors will be watching execution metrics—such as wafer starts and yield ramp rates—as key indicators of whether Intel can fully capitalize on this strategic pivot.